These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25989868)

  • 21. Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy*.
    Jenkins DD; Lee T; Chiuzan C; Perkel JK; Rollins LG; Wagner CL; Katikaneni LP; Bass WT; Kaufman DA; Horgan MJ; Laungani S; Givelichian LM; Sankaran K; Yager JY; Martin R
    Pediatr Crit Care Med; 2013 Oct; 14(8):786-95. PubMed ID: 23897243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of darbepoetin alfa in healthy subjects.
    Agoram B; Sutjandra L; Sullivan JT
    Br J Clin Pharmacol; 2007 Jan; 63(1):41-52. PubMed ID: 16939525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration.
    Takama H; Tanaka H; Nakashima D; Ogata H; Uchida E; Akizawa T; Koshikawa S
    Br J Clin Pharmacol; 2007 Mar; 63(3):300-9. PubMed ID: 16945116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings.
    El Shimi MS; Awad HA; Hassanein SM; Gad GI; Imam SS; Shaaban HA; El Maraghy MO
    J Matern Fetal Neonatal Med; 2014 Sep; 27(13):1295-300. PubMed ID: 24134405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
    Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
    Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE
    Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia.
    Balduini W; Weiss MD; Carloni S; Rocchi M; Sura L; Rossignol C; Longini M; Bazzini F; Perrone S; Ott D; Wadhawan R; Buonocore G
    J Pineal Res; 2019 May; 66(4):e12565. PubMed ID: 30734962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia.
    Blumer J; Berg S; Adamson PC; Loew T; Rossi G; Hastings C
    Pediatr Blood Cancer; 2007 Oct; 49(5):687-93. PubMed ID: 17120240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empirical methods to calculate an erythropoiesis-stimulating agent dose conversion ratio in nondialyzed patients with chronic kidney disease.
    Horowitz J; Agarwal A; Huang F; Gitlin M; Gandra SR; Cangialose CB
    J Manag Care Pharm; 2009; 15(9):741-50. PubMed ID: 19954265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of hypoxic-ischemic encephalopathy in neonates treated with hypothermia.
    Shankaran S
    Clin Perinatol; 2014 Mar; 41(1):149-59. PubMed ID: 24524452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine changes in newborns with therapeutic hypothermia after hypoxic ischemic encephalopathy.
    Moon CJ; Youn YA; Yum SK; Sung IK
    J Perinatol; 2016 Dec; 36(12):1092-1096. PubMed ID: 27583390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy.
    Shankaran S; Pappas A; Laptook AR; McDonald SA; Ehrenkranz RA; Tyson JE; Walsh M; Goldberg RN; Higgins RD; Das A;
    Pediatrics; 2008 Oct; 122(4):e791-8. PubMed ID: 18829776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of haemoglobin levels and doses in haemodialysis patients treated with subcutaneous or intravenous darbepoetin alfa: a German prospective, randomized, multicentre study.
    Bommer J; Asmus G; Wenning M; Bommer G
    Nephrol Dial Transplant; 2008 Dec; 23(12):4002-8. PubMed ID: 18676350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assessment of therapeutic passive hypothermia in newborns with hypoxic-ischemic encephalopathy that need interhospital transport].
    Fuentes-Ruiz JA; Lagares-Franco C; Rodríguez-Molina Ó; Cordero-Cañas E; Benavente-Fernández I
    Rev Neurol; 2015 Apr; 60(7):303-8. PubMed ID: 25806479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous injection pain with C.E.R.A., a continuous erythropoietin receptor activator, compared with darbepoetin alfa.
    Pannier A; Jordan P; Dougherty FC; Bour F; Reigner B
    Curr Med Res Opin; 2007 Dec; 23(12):3025-32. PubMed ID: 17961301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis.
    Agarwal AK; Silver MR; Reed JE; Dhingra RK; Liu W; Varma N; Stehman-Breen C
    J Intern Med; 2006 Dec; 260(6):577-85. PubMed ID: 17116009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced hypothermia for neonates with hypoxic-ischemic encephalopathy.
    Long M; Brandon DH
    J Obstet Gynecol Neonatal Nurs; 2007; 36(3):293-8. PubMed ID: 17489937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic Prevention and Treatment of Neonatal Brain Injury.
    McNally MA; Soul JS
    Clin Perinatol; 2019 Jun; 46(2):311-325. PubMed ID: 31010562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of nucleated red blood cells and severity of encephalopathy in normothermic and hypothermic infants.
    Walsh BH; Boylan GB; Dempsey EM; Murray DM
    Acta Paediatr; 2013 Feb; 102(2):e64-7. PubMed ID: 23157330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of intravenous darbepoetin alfa administered once every 2 weeks in chronic kidney disease patients on haemodialysis.
    Carrera F; Oliveira L; Maia P; Mendes T; Ferreira C
    Nephrol Dial Transplant; 2006 Oct; 21(10):2846-50. PubMed ID: 16891642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.